Soligenix Shares Rise 19% After Vaccine Trial Shows Protection Against Two Viruses
By Ben Glickman Shares of Soligenix were higher Tuesday after a trial of the company's vaccine candidate showed protection against two viruses. The stock was...
Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ben Glickman Shares of Soligenix were higher Tuesday after a trial of the company's vaccine candidate showed protection against two viruses. The stock was...
By Chris Wack Atai Life Sciences saw positive results from its Phase 1 study evaluating orally administered EMP-01. The goals of this Phase 1 study were to...
Health-care companies rose as traders rotated back to the sector from more cyclical niches of the market. Shares of obesity drug maker Novo Nordisk rose to...
By Josh Beckerman Iovance Biotherapeutics shares were recently up 17% following a 19% decline on Wednesday after the company reported a clinical hold in a...
By Adriano Marchese NKGen Biotech said Wednesday it has received regulatory clearance to begin trials for its cell therapy to treat patients with moderate...